Skip to Content

CREON 1236 (Creon 180,000 units amylase / 36,000 units lipase / 114,000 units protease)

Generic Name: pancrelipase

This pill with imprint "CREON 1236" is Blue / Clear, Capsule-shape and has been identified as Creon 180,000 units amylase / 36,000 units lipase / 114,000 units protease. It is supplied by AbbVie, Inc..

Creon is used in the treatment of chronic pancreatitis; pancreatic exocrine dysfunction; cystic fibrosis and belongs to the drug class digestive enzymes. Risk cannot be ruled out during pregnancy. Creon 180,000 units amylase / 36,000 units lipase / 114,000 units protease is not a controlled substance under the Controlled Substance Act (CSA).

Images for CREON 1236

Creon

Generic Name:
pancrelipase
Imprint:
CREON 1236
Strength:
180,000 units amylase / 36,000 units lipase / 114,000 units protease
Color:
Blue / Clear
Shape:
Capsule-shape
Availability:
Rx and/or OTC
Drug Class:
Digestive enzymes
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
AbbVie, Inc.
National Drug Code (NDC):
00032-3016

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide